胰腺癌患者使用厄洛替尼治疗后出现睫毛粗长症。
Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas.
作者信息
Goel Varun, Raina Shubhra, Chandragouda D, Singh Sajjan, Talwar Vineet, Patnaik Nivedita
机构信息
Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
Department of Pathology, University College of Medical Sciences, Guru Teg Bahadur Hospital, New Delhi, India.
出版信息
Int J Trichology. 2014 Jan;6(1):23-4. doi: 10.4103/0974-7753.136755.
Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair.
表皮生长因子受体（EGFR）抑制剂已被广泛用于治疗上皮性恶性肿瘤。接受EGFR抑制剂治疗的患者中出现了各种各样的皮肤毒性反应。睫毛粗长，尤其是睫毛的这种情况是该治疗方法罕见的副作用。我们报告了一例39岁男性胰腺癌患者出现睫毛粗长的病例。这些药物的这种副作用为刺激头发生长的治疗带来了前景。
Zotero 插件